Compugen Ltd.
Price Action
Technical Summary
EMERGING TRENDCompugen Ltd. shows underlying uptrend characteristics but has temporarily lost support at the 50-day moving average. Relative strength is moderate (RS Rating: 72), indicating performance broadly in line with the market. Earnings growth of 201% provides fundamental context to the price action. Investors should exercise caution due to high volatility (68% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $2.09 | +14.30% | ABOVE |
| 50 SMA | $2.45 | -2.45% | BELOW |
| 100 SMA | $2.32 | +2.88% | ABOVE |
| 150 SMA | $2.12 | +12.62% | ABOVE |
| 200 SMA | $2.01 | +18.96% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is CGEN in an uptrend right now?
CGEN has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is CGEN overbought or oversold?
CGEN's RSI (14) is 58. The stock is in neutral territory, neither overbought nor oversold.
Is CGEN outperforming the market?
CGEN has a Relative Strength (RS) Rating of 72 out of 99. CGEN is performing about average compared to the market.
Where is CGEN in its 52-week range?
CGEN is trading at $2.39, which is 74% of its 52-week high ($3.23) and 56% above its 52-week low ($1.30).
How volatile is CGEN?
CGEN has a Beta of 1.67 and 52-week volatility of 68%. It's more volatile than the S&P 500 - expect bigger swings.